21-Nov-2026 11:37:36
NATCOPHARMGeneral news
NATCO PHARMA : USFDA ISSUES 7 FORM-483 OBSERVATIONS AT KOTHUR PLANT
• USFDA inspected the company's Kothur, Hyderabad formulation manufacturing facility from 12 November to 20 November 2026 • Company received seven observations in Form-483 upon conclusion of the inspection • Natco says the observations are procedural in nature and it is confident of addressing them within stipulated timelines • Kothur is a formulation plant serving regulated markets approved by USFDA, Brazil ANVISA, Health Canada and WHO
Natco Pharma Limited
Open attachment